Odyssey Therapeutics, Inc. (ODTX)
$25.98+1.41%Close
BUY
Key stats
Short interest · FINRA settlement 2026-08-14
- Market cap
- $785M
- Avg volume
- 325.8K
- Beta
- 1.43
- P/E (TTM)
- -10.19
- Short % float
- 8.79%
- Days to cover
- 18.7
- SI change
- -0.9%
- 1W
- +5.31%
- 1M
- +43.93%
- 3M
- +44.98%
- YTD
- +58.22%
- vs SPY 1W
- +4.20%
- vs SPY 1M
- +38.23%
- vs SPY 3M
- +42.79%
- vs SPY YTD
- +45.35%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- ATRABUYAtara Biotherapeutics, Inc.RECOVERYQ -7$9.25-1.39%
- TNDMBUYTandem Diabetes Care, Inc.RECOVERYQ -7$21.40+0.14%
- BDXBUYBecton, Dickinson and CompanyBULLQ 18$188.13-1.09%
- DXRSELLDaxor CorporationBEARQ 13$9.67-3.59%
- FONRBUYFONAR CorporationBULLQ 12$19.09+0.00%
- KRMDSELLKORU Medical Systems, Inc.CRISISQ 19$3.20-0.31%
- AGENBUYAgenus Inc.RECOVERYQ -0$7.81-5.33%
- FPCGBUYAvem Health Partners, Inc.BULLQ 6$1025.00+0.00%
- RDYBUYDr. Reddy's Laboratories LimitedRECOVERYQ 14$12.16-0.49%
- PTGXBUYProtagonist Therapeutics, Inc.BULLQ 33$149.50-1.32%
- FTHBUYRECOVERYQ -5$33.74+2.34%
- TRLVBUYRECOVERYQ 14$11.03-3.50%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 25
- VALUE
- 15
- GROWTH
- 47
- GARP
- 10
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC106.6%
REV YoY-
ROE177.7%
EPS YoY-
ROA-18.8%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-10.19
P/E FWD-
SECTOR PE22.44
INDUSTRY PE17.24
P/B1.87
P/FCF-
EV/EBITDA-13.42
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E5.89
ALTMAN Z-
CURR RATIO11.36
ND/EBITDA-
BETA1.43
